Effect of transfection and passage number of ear fibroblasts on in vitro development of bovine transgenic nuclear transfer embryos.
The objective of this study was to determine if the transfection of human prourokinase (ProU) gene and passage number of transfected ear fibroblasts affected in vitro development of bovine transgenic nuclear transfer (NT) embryos. An expression plasmid for human ProU was constructed by inserting a bovine beta-casein promoter, a green fluorescent protein (GFP) marker and human ProU gene into a pcDNA3 plasmid and transfected into bovine ear fibroblasts using a lipid mediated method. Abattoir derived oocytes were enucleated at 18-20 hr post maturation and a single donor cell was transferred into the perivitelline space of a recipient oocyte. After fusion and activation, the couplets were cultured in modified synthetic oviductal fluid (mSOF) medium for 168 hr. In Experiment 1, significantly lower rate in blastocysts formation (10.3%) was observed in transfected donor cells at early passage than that in nontransfected counterparts (22.1%, P<0.05). In Experiment 2, development to blastocysts and GFP expression in blastocysts were not significantly different between early (3-7) and late (8-12) passage donor cells (10.3 vs. 11.3% and 54.5 vs. 41.7%, respectively). This study indicates that in vitro development of bovine transgenic NT embryos is negatively influenced by transfection of human ProU gene into donor fibroblasts. However, passage number of transfected ear fibroblasts does not affect in vitro development of bovine transgenic NT embryos.
Bhuiyan
M M U
MM
College of Veterinary Medicine, Seoul National University, Korea.
Cho
Jongki
J
Jang
Goo
G
Park
Eulsoon
E
Kang
Sungkeun
S
Lee
Byeongchun
B
Hwang
Woosuk
W
D000818:Animals; D030801:Animals, Genetically Modified / Q000196:embryology* / Q000235:genetics; D002417:Cattle / Q000235:genetics*; D019976:Cloning, Organism; D004431:Ear, External / Q000166:cytology; D005347:Fibroblasts / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D010957:Plasmids / Q000235:genetics; D011994:Recombinant Proteins / Q000235:genetics*; D014162:Transfection; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics* / Q000502:physiology
D011994:Recombinant Proteins; D014568:Urokinase-Type Plasminogen Activator; C067551:saruplase